Drug Profile
ARD 111421
Alternative Names: AR-D111421Latest Information Update: 15 Sep 2000
Price :
$50
*
At a glance
- Originator AstraZeneca
- Class Antiasthmatics
- Mechanism of Action Vasoactive intestinal peptide receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 15 Sep 2000 Discontinued-II for Asthma (Unknown route)
- 27 Jan 2000 New profile
- 27 Jan 2000 Phase-II clinical trials for Asthma (Unknown route)